loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Diazoxide

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Diazoxide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,647Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Soleno Therapeutics Announces Inducement Grants Under Nasdaq Rule
    Soleno Therapeutics Announces Inducement Grants Under Nasdaq Rule

    19 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/19/2932445/0/en/Soleno-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    19 Aug 2024
    Share Share
    Soleno Submits New Drug Application To FDA For DCCR To Treat Willi Syndrome
    Soleno Submits New Drug Application To FDA For DCCR To Treat Willi Syndrome

    28 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/28/2905801/0/en/Soleno-Therapeutics-Announces-Submission-of-New-Drug-Application-to-the-U-S-FDA-for-DCCR-Diazoxide-Choline-Extended-Release-Tablets-for-the-Treatment-of-Prader-Willi-Syndrome.html

    GLOBENEWSWIRE
    28 Jun 2024
    Share Share
    Soleno Announces DCCR Prader-Willi Data At ENDO 2024
    Soleno Announces DCCR Prader-Willi Data At ENDO 2024

    22 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/22/2886835/0/en/Soleno-Therapeutics-Announces-Oral-Presentation-featuring-DCCR-Diazoxide-Choline-Extended-Release-Tablets-in-Prader-Willi-Syndrome-at-ENDO-2024.html

    GLOBENEWSWIRE
    22 May 2024
    Share Share
    Soleno's DCCR Gets FDA Breakthrough Designation in PWS
    Soleno's DCCR Gets FDA Breakthrough Designation in PWS

    29 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/29/2871167/0/en/Soleno-Therapeutics-Receives-Breakthrough-Therapy-Designation-from-U-S-FDA-for-DCCR-Diazoxide-Choline-Extended-Release-Tablets-in-Prader-Willi-Syndrome-PWS.html

    GLOBENEWSWIRE
    29 Apr 2024
    Share Share
    Soleno Presents Positive Long-Term Data for Prader-Willi Syndrome Treatment
    Soleno Presents Positive Long-Term Data for Prader-Willi Syndrome Treatment

    15 Jun 2022

    // TRIALSITENEWS

    https://www.trialsitenews.com/a/soleno-therapeutics-presents-positive-long-term-data-for-prader-willi-syndrome-treatment-199bbbd3

    TRIALSITENEWS
    15 Jun 2022
    Share Share
    Soleno Provides Regulatory Update on DCCR for Prader-Willi Syndrome
    Soleno Provides Regulatory Update on DCCR for Prader-Willi Syndrome

    24 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/24/2371628/0/en/Soleno-Therapeutics-Provides-Regulatory-Update-on-DCCR-for-the-Treatment-of-Prader-Willi-Syndrome.html

    GLOBENEWSWIRE
    24 Jan 2022
    Share Share